These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hilar cholangiocarcinoma: pathology and tumor biology. Kuang D; Wang GP Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Bickenbach K; Galka E; Roggin KK Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808 [TBL] [Abstract][Full Text] [Related]
27. Management and extent of resection for intrahepatic cholangiocarcinoma. Carpizo DR; D'Angelica M Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813 [TBL] [Abstract][Full Text] [Related]
28. The role of radiation therapy in intrahepatic cholangiocarcinoma. Metz JM Cancer J; 2006; 12(2):102-4. PubMed ID: 16630398 [No Abstract] [Full Text] [Related]
29. A case of mucin-producing cholangiocarcinoma. Matsuba H; Sakamoto Y Jpn J Clin Oncol; 2009 Jul; 39(7):467. PubMed ID: 19553400 [No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Advances in the Multidisciplinary Management of Intrahepatic Cholangiocarcinoma. Cloyd JM; Ejaz A; Pawlik TM Ann Surg Oncol; 2020 Aug; 27(8):2866-2867. PubMed ID: 32444910 [No Abstract] [Full Text] [Related]
31. Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma. Ruff SM; Diaz DA; Pitter KL; Hartwell BC; Pawlik TM CA Cancer J Clin; 2023; 73(4):346-352. PubMed ID: 37046405 [No Abstract] [Full Text] [Related]
32. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Balsano C; Conti B; Arciello M Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009 [No Abstract] [Full Text] [Related]
33. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145 [TBL] [Abstract][Full Text] [Related]
34. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
35. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct. Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820 [No Abstract] [Full Text] [Related]
37. Cholangiocarcinoma: estrogen-induced autocrine effects of VEGF on cell proliferation. DeMorrow S Dig Liver Dis; 2009 Feb; 41(2):164-5. PubMed ID: 19112054 [No Abstract] [Full Text] [Related]
38. Cholangiocarcinoma: new insights into disease pathogenesis and biology. Braconi C; Patel T Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455 [TBL] [Abstract][Full Text] [Related]
39. Cholangiocarcinoma--what level of evidence should we have? Abrams RA Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):1-2. PubMed ID: 19100917 [No Abstract] [Full Text] [Related]
40. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]